The Quantellect read.As of Nov 19, 2026, 3 active firms cover Strata Critical Medical, Inc: 3 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $8.00 to $8.00, so the covering firms are broadly aligned. The average target of $8.00 sits 61% above the current $4.96. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.01 next quarter toward $0.08 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 active firms
Buy
Strong Buy00%
Buy3100%
Neutral00%
Sell00%
Strong Sell00%
Based on 3 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$8.00
+61.5% upside
Average target across 3 active firms as of Nov 19, 2026 vs $4.96 current
Highest Target$8.00
Average Target$8.00
Lowest Target$8.00
Detailed analyst forecasts for SRTA
Showing 1–3 of 3 named analysts shown · 3 active firms in the rating projection
As of Nov 19, 2026, 3 of 3 active firms rate SRTA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
SRTA EPS & revenue forecast
EPS · NEXT QUARTER
$0.01
Range $-0.01 – $0.02 · 4 analysts · -67% YoY
Next period, 4 analysts expect Strata Critical Medical, Inc. to earn $0.01 a share (range $-0.01 – $0.02), versus $0.03 a year earlier. Full-year consensus is $-0.16, growing to $0.08 the year after.
REVENUE · NEXT QUARTER
$79.3M
Range $76.9M – $82.1M · 4 analysts · +18% YoY
Revenue is expected to reach $79.3M (range $76.9M – $82.1M), +17.6% year-over-year. Full-year consensus is $289.9M, rising to $325.1M next year.
Top analysts covering Strata Critical Medical, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SRTA.
#1
Ben Klieve
Lake Street · Rank #529
Buy
$7.25+46.3% to target
Overall win rate
26%
+ Follow
#2
YZ
Yuan Zhi
B. Riley Securities
Buy
$8.00+61.5% to target
Coverage
—
+ Follow
#3
BH
Ben Haynor
Lake Street
Buy
$9.50+91.7% to target
Coverage
—
+ Follow
#4
WB
William Bonello
Craig-Hallum
Buy
No targeton SRTA
Coverage
—
+ Follow
#5
JH
Jon Hickman
Ladenburg Thalmann
Buy
$11.50+132.1% to target
Coverage
—
+ Follow
SRTA stock forecast FAQ
What is SRTA's average 12-month price target?+
The 3 active firms with a live target average $8.00 for Strata Critical Medical, Inc. over the next 12 months, ranging from a $8.00 high to a $8.00 low, as of Nov 19, 2026.
Is SRTA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 3 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
How many active Wall Street firms cover SRTA?+
3 active firms have a recognized rating on Strata Critical Medical, Inc. as of Nov 19, 2026, and 3 active firms carry a live 12-month price target.
Who is the most accurate analyst covering SRTA?+
Among analysts who currently cover SRTA, Ben Klieve of Lake Street has the strongest overall Quantellect track record (Rank #529). Their current call is Buy with a $7.25 target.
What is Strata Critical Medical, Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.01 per share (range $-0.01 – $0.02) across 4 analysts. Full-year EPS is projected at $-0.16, rising to $0.08 the following year.
How much revenue is Strata Critical Medical, Inc. expected to report next quarter?+
Consensus revenue is $79.3M (range $76.9M – $82.1M). Full-year revenue is projected at $289.9M, growing to $325.1M next year.
Have analysts been upgrading or downgrading SRTA lately?+
As of Nov 19, 2026, 3 of 3 active firms rate SRTA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SRTA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.